RE: Pre-clinical trial NXP00424 Aug 2020 23:00
Halespur, pretty difficult to figure out how much the spent on NXP002 given the other things going on at the time. We do know that it took them about 10 months with NXP002 to do the next stage.
At the moment we know that since end of sept they have spent about 800k, of which salaries are about 200k leaving £500k in the bank plus a couple of milestone payments we don’t know the value of.
So, given they’ll pay a bit less in salaries not DG / DT / KSW et al have gone, they’ve got a bit to play with if fee for services continue to come through.